Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth.
Maria PapadopoulouTanya DimovaMuki SheyLibby BrielHelen VeldtsmanNondumiso KhombaHadn AfricaMarcia SteynWillem A HanekomThomas Jens ScribaElisa NemesDavid VermijlenPublished in: Proceedings of the National Academy of Sciences of the United States of America (2020)
Vγ9Vδ2 T cells are a major human blood γδ T cell population that respond in a T cell receptor (TCR)-dependent manner to phosphoantigens which are generated by a variety of microorganisms. It is not clear how Vγ9Vδ2 T cells react toward the sudden microbial exposure early after birth. We found that human Vγ9Vδ2 T cells with a public/shared fetal-derived TCR repertoire expanded within 10 wk postpartum. Such an expansion was not observed in non-Vγ9Vδ2 γδ T cells, which possessed a private TCR repertoire. Furthermore, only the Vγ9Vδ2 T cells differentiated into potent cytotoxic effector cells by 10 wk of age, despite their fetal origin. Both the expansion of public fetal Vγ9Vδ2 T cells and their functional differentiation were not affected by newborn vaccination with the phosphoantigen-containing bacillus Calmette-Guérin (BCG) vaccine. These findings suggest a strong and early priming of the public fetal-derived Vγ9Vδ2 T cells promptly after birth, likely upon environmental phosphoantigen exposure.
Keyphrases
- healthcare
- regulatory t cells
- endothelial cells
- mental health
- gestational age
- induced apoptosis
- induced pluripotent stem cells
- emergency department
- microbial community
- pluripotent stem cells
- health insurance
- dendritic cells
- immune response
- cell proliferation
- cell cycle arrest
- climate change
- muscle invasive bladder cancer
- bacillus subtilis
- high throughput sequencing